Lecturers

ISOBM2020 Lecturers

(tentative list at the moment)

Lecturers

Lecturer Title of Lecture
Barak Vivian (ISR)  – sIL-2R- an important Immuno- Biomarker for Cancer
Bendas G (GER)  to be announced
Blatnik Ana (SLO) Genetic modifiers of risk in hereditary cancer – an analysis of Slovenian NBN 657del5 carriers
Boltežar Gašper (SLO) Tumour markers of mucinoses cists of pancreas
Bombač Alenka (SLO) Mutational spectrum in patients with metastatic gastrointestinal stromal tumours treated at Institute of Oncology Ljubljana
Bronkhorst A (ZAR) Understanding biology of cell-free nucleic acids for clinical decision making
Chechlinska Magdalena (POL) Molecular profiling of ovarian tumour microenvironment
Colas Ortega Eva (ESP) Use of biomarkers in diagnosis and presurgical patient stratification
Danesi Romano (ITA) Clinical implementation of pharmacogenetics to reduce the risk of toxicity of anticancer drugs
Datar Vineet (IND) New Dynamics in Cancer Outcomes: Encyclopaedic Tumour Analysis
Del Re Marizia (ITA) The application of liquid biopsy to cancer treatment monitoring
Devjak Rok (SLO) Oncogenic driver EGFR mutation in NSCLC with case report
Diamandis P. Eleftherios (CAN) Circulating tumour DNA for early cancer detection
Duffy Joe (IRL) Personalised treatment for cancer: biomarkers are showing the way
Einarsson Roland (SWE) Bladder Cancer detection by UBC rapid
Fanfani Francesco (ITA) Personalised surgical approach in early endometrial cancer according to bimolecular profile
Ferrari Paola (ITA) Inhibiting immunosuppression immunotherapy in solid tumors
Fishmann Dmytro (EST) Machine learning in medicine
Fritche, Herb (USA) Ovarian cancer markers
Garrido Manuel (PRT) Multi-biomarker panels for risk stratification in prostate cancer patients with PSA between 2 and 10 ng/ml
Habermann Jens (GER) to be announced
Haselmann Verena (GER) Liquid biopsy for immune therapies
van den Heuvel Michael (NED) Biomarker guided treatment of patients with advanced lung cancer
Holdenrieder Stefan (GER) Proteomic and metabolomics multimarker approaches for lung cancer
Illig Thomas (GER) The relevance of high-quality bio banking in research
Janša Rado (SLO) Clinical importance of alpha-fetoprotein in hepatocellular carcinoma
Kagan  Jacob (USA) Validation Studies of Biomarkers for Early Detection of Aggressive Prostate Cancer
Karlikova Marie (CZE) Importance of Matrix metalloproteinases in tumour diseases
Kinkorova Judita (CZE) Biobanks in Corona Pandemy
Klawonn Frank (GER) Biostatistic approaches for evaluation of complex longitudinal ring trial data
Kloft Charlotte (GER) to be announced
Krüger Kimberly (GER) Proteomic and metabolomic multimarker approaches for lung cancer
Kučera Radek (CZE) The importance of PHI for the prediction of surgical solution or active surveillance of prostate cancer patients
Lainšček Duško (SLO) An enhanced CRISPR based tool for treating chronic myelogenous leukaemia
Leendert Looijenga (NED) Human germ cell tumours; clinical implementation of laboratory findings
Marc Janja (SLO) Biomarkers in bone metastasis
Mlinarič-Raščan Irena (SLO) Prostaglandin E Receptor 4 Agonist as Promising Therapeutic Agent for Treatment of Chronic Lymphocytic Leukaemia
Muley Thomas (GER) Use of tumor marker classificators for post-surgery stratification of patients with early lung cancer
Nazarenko Irina (GER) to be announced
Nicolini Andrea (ITA) A new immunotherapy schedule in metastatic endocrino-dependent breast cancer patients
Norčič Gregor (SLO) Potential clinical use of liquid biopsy in abdominal surgery
Ohta Nobuhio (ROC) Autofluorescence lifetime microscopy and nanosecond pulsed electric field effects in live cells: A comparison between cancerous cells and non-malignant normal cells
Oehr Peter (JPN) New established types of ROC-curves and their innovative clinical impact
Osredkar Joško (SLO) National screening programmes; how and when?
Pečen Ladislav (CZE) Decision support systems for the interpretation of tumor markers
Pfaffl Michael (GER) to be announced
Rebmann V (GER) to be announced
Reijnen Casper (NED) Integrating biomarkers into ENDORISK prediction model
Ritter Christoph (GER) to be announced
Romano Andrea (NED) Hormonal treatment in gynaecologic malignancy. Is there a place?
van Rossum Huub (NED) Algorithms for classification of response to therapy in lung cancer patients
Roychowdhury Ansuya (IND) HIF1alpha-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia
Schippan Inga (GER) Risk prediction for GvHD in patients with AML after stem cell transplantation
Schroeder Christoph (GER) Affinity proteomics for the discovery of novel biomarkers and therapeutic targets
Sever Matjaž (SLO) Clinical implication of CART therapy
Smrkolj Tomaž (SLO) Biomarkers in urology
Song Erwei (CHN) Combating the microenvironment of breast cancer
Stegel Vida (SLO) Genetic testing of ovarian tumour samples at the Institute of oncology Ljubljana
Strojnik Ksenija (SLO) Germline genetic testing for cancer treatment in prostate and pancreatic cancer patients
Škerl Petra (SLO) Methylation status of mismatch repair genes in endometrial and colorectal cancer
Škof Erik (SLO) Clinical importance of BRCA mutation in ovarian cancer
Šmid Lojze (SLO) Chromogranin in the diagnostic and therapy of neuroendocrine tumours
Šterajčič Dragoš Vita (SLO) The use of RNAseq in discovery of splicing abnormalities
Thakur B (GER) to be announced
Tokarz Janina (GER) Metabolomics for deep phenotyping in frequent human diseases
Topolčan Ondrej (CZE) Significance tumour biomarkers for tumour aggressiveness
Turnšek Nina (SLO) Oncogenic driver ALK fusion in NSCLC with case report
Uhlig Carsten (GER) Artificial intelligence approaches for tumor marker evaluations
Ungerer V (GER) Epigenetic changes of circulating nucleosomes as new cancer biomarkers
Unk Mojca (SLO) (R)Evolution of non-small cell lung cancer systemic treatment
Viehbaum Laura (GER) Longitudinal inter-lab and inter-manufacturer comparison of gastrointestinal and gynecological tumor markers
Windrichova Jindra (CZE) Digital PCR assessment of KRAS mutations in plasma cell-free DNA in liver metastatic colorectal cancer
Wojtajewicz Natalie (POL) Longitudinal inter-lab and inter-manufacturer comparison of lung and urological tumor markers
Zagorac Andreja (SLO) Evaluation of Xpert®Bladder Cancer Detection and UroVysion Bladder Cancer Kit in detection of bladder cancer

ENITEC Section

Lecturer Title of Lecture
Alicia Leon del Castillo (NLD) TCGA classification in endometrial cancer and beyond
Casper Reijnen (NLD) Integrating biomarkers into ENDORISK prediction model
Francesco Fanfani (ITA) Personalised surgical approach in early endometrial cancer according to bimolecular profile
Eva Colas Ortega (ESP) Use of biomarkers in diagnosis and presurgical patient stratification

BioEndoCar Section

Lecturer Title of Lecture
Thomas Illig (GER) The relevance of high-quality biobanking in research
Janina Tokarz (GER) Metabolomics for deep phenotyping in frequent human diseases
Christoph Schroeder (GER) Affinity proteomics for the discovery of novel biomarkers and therapeutic targets
Dmytro Fishman (EST) Machine learning in medicine